Diamedica Therapeutics (DMAC) Stock Research

Today

DiaMedica Therapeutics reports Q2 EPS (19c), consensus (20c)

DMAC

4:39 PM

Over a week ago

DiaMedica Therapeutics announces dosing of first two patients in DM199 study

DMAC

Jun 23, 8:32 AM

DiaMedica Therapeutics receives written response from FDA on DM199

DMAC

Jun 16, 8:33 AM

DiaMedica announces 75% enrollment milestone in ReMEDy2 Phase 2/3 trial

DMAC

May 20, 8:38 AM

DiaMedica sees cash, equivalents funding operations through 2027

DMAC

May 6, 4:45 PM

DiaMedica Therapeutics reports Q1 EPS (19c), consensus (19c)

DMAC

May 6, 4:44 PM

DiaMedica Therapeutics reports FY25 EPS (70c), consensus (68c)

DMAC

Mar 30, 4:48 PM

DiaMedica Therapeutics receives Health Canada clearance to initiate DM199 study

DMAC

Mar 5, 7:49 AM

Omega takes new stake in Rocket Companies, exits ArriVent Biopharma

+13

Feb 17, 10:21 AM

DiaMedica Therapeutics named a Top Idea for 2026 at Lake Street

DMAC

Jan 5, 8:40 AM

DiaMedica Therapeutics provides DM199 update following FDA meeting

DMAC

Dec 18, 9:12 AM

Microsoft initiated, Home Depot downgraded: Wall Street's top analyst calls

+15

Nov 14, 9:38 AM

DiaMedica Therapeutics initiated with bullish view at Cantor Fitzgerald, here's why

DMAC

Nov 14, 8:08 AM

DiaMedica Therapeutics initiated with bullish view at Cantor Fitzgerald

DMAC

Nov 14, 6:19 AM

DiaMedica Therapeutics reports Q3 EPS (17c), consensus (16c)

DMAC

Nov 12, 4:34 PM

DiaMedica Therapeutics initiated with bullish view at TD Cowen, here's why

DMAC

Oct 30, 7:00 AM

DiaMedica Therapeutics files $100M mixed securities shelf

DMAC

Aug 12, 5:11 PM

DiaMedica Therapeutics reports Q2 EPS (18c), consensus (19c)

DMAC

Aug 12, 4:19 PM

No more stories